DOCSLIB.ORG

Neonatal Fever V6.0: ED Phase (0-28 Days Old)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Neonatal Fever V6.0: ED Phase (0-28 Days Old) Neonatal Fever v6.0: ED Phase (0-28 days old) Approval & Citation Summary of Version Changes Explanation of Evidence Ratings PHASE I (E.D.) Inclusion Criteria · Fever ≥38 C (or a reliable Urgent Care Transfer history of fever) or hypothermia Guidelines (for 0-28 days) <36 C in children <28 days of age Well appearing neonates with fever transfer via POV to an ED Exclusion Criteria · Patients currently admitted to Ill appearing neonates with fever: ICU or admitted >3 days · Initiate transport immediately · Known immunodeficiency or · Attempt to obtain labs cancer · Give antibiotics (IV or IM) · Patients with central venous catheters or VP shunts ! Other differential Begin clinical assessment diagnosis for severely ill neonates Focal Infection Off Yes (e.g., omphalitis, pneumonia) Pathway CSF Normative values No 0-1 month: CSF WBC <20/mm3 HSV work up indications >I month: CSF WBC Perform c o m p l e t e w o r k u p and begin <10/mm3 acyclovir for any of the following: · UA, urine culture Historical and clinical features · CBC with diff, Blood culture · severe illness · CSF studies · hypothermia · lethargy ! · HSV work up if indicated (see box) · CXR and respiratory viral panel (if · seizures respiratory symptoms) · hepatosplenomegaly If CSF · postnatal HSV contact pleocytosis · Stool PCR (if diarrhea) · vesicular rash consider · conjunctivitis CSF Rapid Viral Qual. · interstitial pneumonitis PCR Laboratory features · thrombocytopenia · CSF pleocytosis >20 WBC/mm3 Inability to obtain Begin empiric treatment without clear bacterial infection CSF in ED · Ampicillin and cefotaxime (or ceftazidime if (e.g., + Gram stain) CCoonnssiiddeerrationss ffoorr cefotaxime unavailable) PPrrettreated CCSSFF · Acyclovir if HSV work up performed · Admit all patients · Administer antibiotics (GOAL: within 60 minutes) ! · Refer to IR for lumbar Go to In well- puncture as inpatient appearing · Rapid CSF Bacterial PCR Inpatient infants with can be sent on pre-treated Phase multiple maternal CSF that demonstrates (0-28d) HSV risk factors, pleocytosis consider HSV work up For questions concerning this pathway, Last Updated: August 2019 contact: [email protected] Next Expected Revision: January 2024 © 2019 Seattle Children’s Hospital, all rights reserved, Medical Disclaimer Neonatal Fever v6.0: ED Phase (29-56 days old) Approval & Citation Summary of Version Changes Explanation of Evidence Ratings PHASE I (E.D.) Urgent Care Transfer Inclusion Criteria Guidelines (for 29-56 days) · Fever ≥38 C (or a reliable history of fever) or hypothermia Ill appearing neonates with <36 C in children 29-56 days of fever: age · Initiate transport immediately Exclusion Criteria · Attempt to obtain labs · Patients currently admitted to · Give antibiotics (IV or IM) ICU or admitted >3 days · Known immunodeficiency or Does not meet low risk criteria: cancer · Transfer to ED for additional · Patients with central venous work up and antibiotics ! catheters or VP shunts If CSF pleocytosis consider Focal Infection Off Yes CSF Rapid Viral Qual. (e.g., omphalitis, pneumonia) Pathway PCR No Bronchiolitis? CONSIDER (increased work of breathing, cough, Yes NEONATAL FEVER 29- tachypnea, wheezing) 56 days W/BRONCH ED PHASE No Low Risk Criteria Inability to obtain · Well-appearing CSF in ED · Previously healthy Considerations for · CBC with diff Considerations for · Full term (≥37 weeks) PPrertertereaatetedd C CSSFF · No focal bacterial infection · Blood culture · Negative urinalysis · UA, urine culture · Administer antibiotics · WBC >5,000 and <15,000 mm3 · CXR and respiratory viral panel 3 (GOAL: within 60 minutes) · Absolute bands <1,500 mm (if respiratory symptoms) · Refer to IR for lumbar · No discrete infiltrates on CXR if · Stool PCR (if diarrhea) puncture as inpatient done · Rapid CSF Bacterial PCR can be sent on pre-treated CSF that demonstrates pleocytosis ! Meets all low risk criteria? Ceftriaxone contraindicated with hyperbilirubinemia · Obtain CSF studies · Begin ceftriaxone Yes No · Considerations for severely ill patients and other clinical scenarios · Admit Discharge Criteria (meets all) · Eating well and well appearing · No social/family concerns Go to · Reliable follow-up in 12- No Inpatient 24 hours Admit for observation Phase · Outpatient plan accepted CSF studies and antibiotics if worsens by PMD and family (29-56d) For questions concerning this pathway, contact: [email protected] Last Updated: August 2019 © 2019 Seattle Children’s Hospital, all rights reserved, Medical Disclaimer Next Expected Revision: January 2024 Neonatal Fever v6.0: Inpatient Phase (0-28 days old) Approval & Citation Summary of Version Changes Explanation of Evidence Ratings PHASE II (INPATIENT) Inclusion Criteria · Fever ≥38 C (or a reliable history of fever) or hypothermia <36 C in children <28 days of ! age Exclusion Criteria If CSF · Patients currently admitted to pleocytosis ICU or admitted >3 days consider Known immunodeficiency or CSF Rapid Viral Qual. · PCR cancer · Patients with central venous catheters or VP shunts Yes CSF Pleocytosis No Review Urinalysis >20WBC/mm3? results Positive Negative Cefotaxime Ampicillin + Ampicillin + Monotherapy Cefotaxime gentamicin (or Ceftazidime if (or Ceftazidime if Cefotaxime unavailable) When to Cefotaxime unavailable) discontinue acyclovir Inability to obtain · Treat specific condition CSF in ED · Narrow antibiotic agent CCoonnssiiddeerrationss ffoorr Daily re-evaluation Pos. cultures if possible PPrrettreated CCSSFF · If HSV+, transfer to ID service · ED administers antibiotics · Refer to IR for lumbar Neg. cultures puncture as inpatient · Rapid CSF Bacterial PCR Improving and meets No Further evaluation can be sent on pre-treated discharge criteria? per primary team CSF that demonstrates pleocytosis Yes Discharge Criteria (Meets all) · Tolerating PO · Well-appearing Discharge · At 36 hours if cultures ! Instructions negative Consider · PMD f/u within · HSV discharge criteria discharge at 48-72 hours · Adequate follow-up 24 hours if non-HSV · PMD and family agree viral studies positive with plan & patient well-appearing For questions concerning this pathway, Last Updated: August 2019 contact: [email protected] Next Expected Revision: January 2024 © 2019 Seattle Children’s Hospital, all rights reserved, Medical Disclaimer Neonatal Fever v6.0: ED Phase (29-56 days old) with Bronchiolitis Approval & Citation Summary of Version Changes Explanation of Evidence Ratings PHASE I (E.D.) Inclusion Criteria · Fever ≥38 C (or a reliable history of fever) or hypothermia <36 C in children 29-56 days of age with signs of bronchiolitis Exclusion Criteria · Patients currently admitted to ICU or admitted >3 days · Known immunodeficiency or ! cancer · Patients with central venous Onset of NEW fever catheters or VP shunts during hospitalization in In patients PRESENTING with patients with bronchiolitis can fever and bronchiolitis, the risk of be indicative of a serious bbaacctteerreemmiiaa aanndd mmeenniinnggiittiiss iiss llooww.. bacterial infection. UTI should be considered in Symptoms of Bronchiolitis: patients who are persistently (increased work of breathing, cough, symptomatic with fever or tachypnea, wheezing) vomiting. Signs of poor perfusion or mental status Continue workup per Neonatal YES changes or sepsis score > 3 Fever (29-56d) pathway NO Consider UA/Culture in patients who are persistently febrile or vomiting UA – OR UA + UA NOT INDICATED Blood CX Off CONSIDER BRONCHIOLITIS Pathway PATHWAY Ceftriaxone Admit to iinpattiientt on UTII and Brronchiiolliittiis pathway For questions concerning this pathway, Last Updated: August 2019 contact: [email protected] Next Expected Revision: January 2024 © 2019 Seattle Children’s Hospital, all rights reserved, Medical Disclaimer Neonatal Fever v6.0: Inpatient Phase (29-56 days old) Approval & Citation Summary of Version Changes Explanation of Evidence Ratings PHASE II (INPATIENT) Inclusion Criteria · Fever ≥38 C (or a reliable history of fever) or hypothermia <36 C in children 29-56 days of ! age Exclusion Criteria If CSF · Patients currently admitted to pleocytosis ICU or admitted >3 days consider Known immunodeficiency or CSF Rapid Viral Qual. · PCR cancer · Patients with central venous catheters or VP shunts · Treat specific condition · Consider LP in patients with ! bacteremia if not done prior Daily re-evaluation Positive cultures · Begin antibiotics if not begun Ceftriaxone prior; narrow antibiotic agent if contraindicated with possible Calcium containing fluids or hyperbili Considerations for Pretreated CSF Negative cultures · Rapid CSF Bacterial PCR can be sent on pre-treated CSF that demonstrates pleocytosis Improving and meets ! discharge criteria? Consider discharge at 24 hours if non-HSV viral studies positive No & patient well-appearing Yes Further evaluation per Discharge Criteria primary team (Meets all) · Tolerating PO · Well-appearing · At 36 hours if cultures negative Discharge and antibiotics begun Instructions · At 24 hours if cultures negative · PMD f/u within and no antibiotics begun 48-72 hours · Adequate follow-up · PMD and family agree with plan For questions concerning this pathway, Last Updated: August 2019 contact: [email protected] Next Expected Revision: January 2024 © 2019 Seattle Children’s Hospital, all rights reserved, Medical Disclaimer Background Fever is a common presenting symptom in neonates and young infants: • 12-28% will have a serious bacterial infection (which include bacteremia/sepsis,
Load more

Recommended publications
  • Administering Unidata on UNIX Platforms
    C:\Program Files\Adobe\FrameMaker8\UniData 7.2\7.2rebranded\ADMINUNIX\ADMINUNIXTITLE.fm March 5, 2010 1:34 pm Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta UniData Administering UniData on UNIX Platforms UDT-720-ADMU-1 C:\Program Files\Adobe\FrameMaker8\UniData 7.2\7.2rebranded\ADMINUNIX\ADMINUNIXTITLE.fm March 5, 2010 1:34 pm Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Notices Edition Publication date: July, 2008 Book number: UDT-720-ADMU-1 Product version: UniData 7.2 Copyright © Rocket Software, Inc. 1988-2010. All Rights Reserved. Trademarks The following trademarks appear in this publication: Trademark Trademark Owner Rocket Software™ Rocket Software, Inc. Dynamic Connect® Rocket Software, Inc. RedBack® Rocket Software, Inc. SystemBuilder™ Rocket Software, Inc. UniData® Rocket Software, Inc. UniVerse™ Rocket Software, Inc. U2™ Rocket Software, Inc. U2.NET™ Rocket Software, Inc. U2 Web Development Environment™ Rocket Software, Inc. wIntegrate® Rocket Software, Inc. Microsoft® .NET Microsoft Corporation Microsoft® Office Excel®, Outlook®, Word Microsoft Corporation Windows® Microsoft Corporation Windows® 7 Microsoft Corporation Windows Vista® Microsoft Corporation Java™ and all Java-based trademarks and logos Sun Microsystems, Inc. UNIX® X/Open Company Limited ii SB/XA Getting Started The above trademarks are property of the specified companies in the United States, other countries, or both. All other products or services mentioned in this document may be covered by the trademarks, service marks, or product names as designated by the companies who own or market them. License agreement This software and the associated documentation are proprietary and confidential to Rocket Software, Inc., are furnished under license, and may be used and copied only in accordance with the terms of such license and with the inclusion of the copyright notice.
    [Show full text]
  • Sepsis: a Guide for Patients & Relatives
    SEPSIS: A GUIDE FOR PATIENTS & RELATIVES CONTENTS ABOUT SEPSIS ABOUT SEPSIS: INTRODUCTION P3 What is sepsis? In the UK, at least 150,000* people each year suffer from serious P4 Why does sepsis happen? sepsis. Worldwide it is thought that 3 in a 1000 people get sepsis P4 Different types of sepsis P4 Who is at risk of getting sepsis? each year, which means that 18 million people are affected. P5 What sepsis does to your body Sepsis can move from a mild illness to a serious one very quickly, TREATMENT OF SEPSIS which is very frightening for patients and their relatives. P7 Why did I need to go to the Critical Care Unit? This booklet is for patients and relatives and it explains sepsis P8 What treatment might I have had? and its causes, the treatment needed and what might help after P9 What other help might I have received in the Critical Care Unit? having sepsis. It has been written by the UK Sepsis Trust, a charity P10 How might I have felt in the Critical Care Unit? which supports people who have had sepsis and campaigns to P11 How long might I stay in the Critical Care Unit and hospital? raise awareness of the illness, in collaboration with ICU steps. P11 Moving to a general ward and The Outreach Team/Patient at Risk Team If a patient cannot read this booklet for him or herself, it may be helpful for AFTER SEPSIS relatives to read it. This will help them to understand what the patient is going through and they will be more able to support them as they recover.
    [Show full text]
  • Oregon Statewide Payroll Application ‐ Paystub Pay and Leave Codes
    Oregon Statewide Payroll Application ‐ Paystub Pay and Leave Codes PAYSTUB PAY AND LEAVE CODES Pay Type Code Paystub Description Detail Description ABL OSPOA BUSINESS Leave used when conducting OSPOA union business by authorized individuals. Leave must be donated from employees within the bargaining unit. A donation/use maximum is established by contract. AD ADMIN LV Paid leave time granted to compensate for work performed outside normal work hours by Judicial Department employees who are ineligible for overtime. (Agency Policy) ALC ASST LGL DIF 5% Differential for Assistant Legal Counsel at Judicial Department. (PPDB code) ANA ALLW N/A PLN Code used to record taxable cash value of non-cash clothing allowance or other employee fringe benefit. (P050) ANC NRS CRED Nurses credentialing per CBA ASA APPELATE STF Judicial Department Appellate Judge differential. (PPDB code) AST ADDL STRAIGHTTIME Additional straight time hours worked within same period that employee recorded sick, holiday, or other regular paid leave hours. Refer to Statewide Policy or Collective Bargaining Agreement. Hours not used in leave and benefit calculations. AT AWARD TM TKN Paid leave for Judicial Department and Public Defense Service employees as years of service award. (Agency Policy) AW ASSUMED WAGES-UNPD Code used to record and track hours of volunteer non-employee workers. Does not VOL HR generate pay. (P050) BAV BP/AWRD VALU Code used to record the taxable cash value of a non-cash award or bonus granted through an agency recognition program. Not PERS subject. (P050 code) BBW BRDG/BM/WELDR Certified Bridge/Boom/Welder differential (PPDB code) BCD BRD CERT DIFF Board Certification Differential for Nurse Practitioners at the Oregon State Hospital of five percent (5%) for all Nurse Practitioners who hold a Board certification related to their assignment.
    [Show full text]
  • Medical Terminology Abbreviations Medical Terminology Abbreviations
    34 MEDICAL TERMINOLOGY ABBREVIATIONS MEDICAL TERMINOLOGY ABBREVIATIONS The following list contains some of the most common abbreviations found in medical records. Please note that in medical terminology, the capitalization of letters bears significance as to the meaning of certain terms, and is often used to distinguish terms with similar acronyms. @—at A & P—anatomy and physiology ab—abortion abd—abdominal ABG—arterial blood gas a.c.—before meals ac & cl—acetest and clinitest ACLS—advanced cardiac life support AD—right ear ADL—activities of daily living ad lib—as desired adm—admission afeb—afebrile, no fever AFB—acid-fast bacillus AKA—above the knee alb—albumin alt dieb—alternate days (every other day) am—morning AMA—against medical advice amal—amalgam amb—ambulate, walk AMI—acute myocardial infarction amt—amount ANS—automatic nervous system ant—anterior AOx3—alert and oriented to person, time, and place Ap—apical AP—apical pulse approx—approximately aq—aqueous ARDS—acute respiratory distress syndrome AS—left ear ASA—aspirin asap (ASAP)—as soon as possible as tol—as tolerated ATD—admission, transfer, discharge AU—both ears Ax—axillary BE—barium enema bid—twice a day bil, bilateral—both sides BK—below knee BKA—below the knee amputation bl—blood bl wk—blood work BLS—basic life support BM—bowel movement BOW—bag of waters B/P—blood pressure bpm—beats per minute BR—bed rest MEDICAL TERMINOLOGY ABBREVIATIONS 35 BRP—bathroom privileges BS—breath sounds BSI—body substance isolation BSO—bilateral salpingo-oophorectomy BUN—blood, urea, nitrogen
    [Show full text]
  • Small Group Instructional Diagnosis: Final Report
    DOCUMENT RESUME JC 820 333 , ED 217 954 AUTHOR Clark, D. Joseph; Redmond, Mark V. TITLE Small Group Instructional Diagnosis: Final Report. INSTITUTION Washington Univ., Seattle. Dept. of Biology c Education. ., 'SPONS AGENCY Fund for the Improwsent of Postsecondary Education . (ED), Washington, D.C. , PUB DATE [82] NOTE 21p.; Appendices mentioned in the report are not _ included. EDRS PRICE , 401/PC01 Plus Postage. DESCRIPTORS *Course Evaluation; *Evaluation Methods; *Instructional Improvement; Postsecondary Education; *Student Evaluation of Teacher Performance;- tudent , Reaction; *Teacher Attitudes; Teacher Workshop IDENTIFIERS *Small group Instructional Diagnosis, ABSTRACT- A procedure for student evaluation andfeedback on faculty instruction was developed at the University of Washington. The system involved the use of,faculty members as facilitatorsin ,conducting Small Group Instructional Diagnosis (SGID) to generate student feedback to instructors about- the courses' strengths, areas needing improvement, and suggestions for bringing about these improvements. The SGID.procedure involves a number of steps:contact between the facilitator and instructor; classroomintervention to ascertain student opinions; a feedback session between facilitator and instructor; instructor. review of the SGID with the class;and ,a follow-up session between the facilitator and instructor.Following the development of the SGID process, handouts andvideotapes were produced to explain the procedure and the SGID technique was demonstrated in over 130 classes
    [Show full text]
  • User Manual for Ox: an Attribute-Grammar Compiling System Based on Yacc, Lex, and C Kurt M
    Computer Science Technical Reports Computer Science 12-1992 User Manual for Ox: An Attribute-Grammar Compiling System based on Yacc, Lex, and C Kurt M. Bischoff Iowa State University Follow this and additional works at: http://lib.dr.iastate.edu/cs_techreports Part of the Programming Languages and Compilers Commons Recommended Citation Bischoff, Kurt M., "User Manual for Ox: An Attribute-Grammar Compiling System based on Yacc, Lex, and C" (1992). Computer Science Technical Reports. 21. http://lib.dr.iastate.edu/cs_techreports/21 This Article is brought to you for free and open access by the Computer Science at Iowa State University Digital Repository. It has been accepted for inclusion in Computer Science Technical Reports by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. User Manual for Ox: An Attribute-Grammar Compiling System based on Yacc, Lex, and C Abstract Ox generalizes the function of Yacc in the way that attribute grammars generalize context-free grammars. Ordinary Yacc and Lex specifications may be augmented with definitions of synthesized and inherited attributes written in C syntax. From these specifications, Ox generates a program that builds and decorates attributed parse trees. Ox accepts a most general class of attribute grammars. The user may specify postdecoration traversals for easy ordering of side effects such as code generation. Ox handles the tedious and error-prone details of writing code for parse-tree management, so its use eases problems of security and maintainability associated with that aspect of translator development. The translators generated by Ox use internal memory management that is often much faster than the common technique of calling malloc once for each parse-tree node.
    [Show full text]
  • Pneumonia in the Context of Severe Sepsis: a Significant Diagnostic Problem
    -1 plasma D-dimer level was low (282 mg?L ). Chest radiography affected by antiphospholipid antibodies syndrome and showed multiple ill-defined increased densities in both lower avoided diagnostic surgery. lung fields. High-resolution computed tomography was then In conclusion, we believe that the indications for use of performed and showed ill-defined, wedge-shaped increased endobronchial ultrasound are manifold and are certainly densities with patent airways in the posterior subpleural greater than those so far recognised. This procedure should regions of both lower lobes. The computed tomography therefore be implemented and further developed in interven- differential diagnosis was organising pneumonia, bronchop- tional pneumology. neumonia, Churg–Strauss syndrome, Wegener granulomato- sis, pulmonary haemorrhage, or vasculitis of various causes. Transbronchial lung biopsy was performed in the right lower G.L. Casoni, C. Gurioli, M. Romagnoli and V. Poletti lobe. Microscopic examination showed alveolar haemorrhage Thoracic Dept, G.B. Morgagni Hospital, Forlı´, Italy. without evidence of vasculitis, eosinophilic infiltration or organising pneumonia. Serum circulating antiphospholipid STATEMENT OF INTEREST antibodies were eventually found. Therefore, pulmonary None declared. angiography was performed and an intra-arterial low density was found in the right main pulmonary artery. This finding SUPPLEMENTARY MATERIAL was believed to be compatible with pulmonary thrombo- This article has supplementary material accessible from embolism; however, it didn’t exclude a possible right www.erj.ersjournals.com pulmonary artery sarcoma. In this case, the only procedure that would rule out the presence of a right pulmonary artery sarcoma (without delays in diagnosis) with any reasonable REFERENCES certainty was surgery. 1 Herth F, Becker HD, LoCicero J 3rd, Ernst A., Endobronchial We decided to perform rigid bronchoscopy under general ultrasound in therapeutic bronchoscopy.
    [Show full text]
  • Fever / Sepsis
    Fever / Sepsis History Signs and Symptoms Differential · Age · Warm · Infections / Sepsis · Duration of fever · Flushed · Cancer / Tumors / Lymphomas · Severity of fever · Sweaty · Medication or drug reaction · Past medical history · Chills/Rigors · Connective tissue disease · Medications Associated Symptoms · Arthritis · Immunocompromised (transplant, (Helpful to localize source) · Vasculitis HIV, diabetes, cancer) · myalgias, cough, chest pain, · Hyperthyroidism · Environmental exposure headache, dysuria, abdominal pain, · Heat Stroke · Last acetaminophen or ibuprofen mental status changes, rash · Meningitis Adult Contact, Droplet, and Airborne Precautions Temperature Measurement Procedure B / if available Pediatric General Section Protocols IV Procedure IO Procedure I P If indicated If indicated Temperature NO Greater than 100.4 F YES (38 C) If Suspected infection ? B then proceed to Protocol 72A otherwise Proceed to Protocol Exit to 72A Appropriate Protocol Pearls · Recommended Exam: Mental Status, Skin, HEENT, Neck, Heart, Lungs, Abdomen, Back, Extremities, Neuro · Febrile seizures are more likely in children with a history of febrile seizures and with a rapid elevation in temperature. · Patients with a history of liver failure should not receive acetaminophen. · Droplet precautions include standard PPE plus a standard surgical mask for providers who accompany patients in the back of the ambulance and a surgical mask or NRB O2 mask for the patient. This level of precaution should be utilized when influenza, meningitis, mumps, streptococcal pharyngitis, and other illnesses spread via large particle droplets are suspected. A patient with a potentially infectious rash should be treated with droplet precautions. · Airborne precautions include standard PPE plus utilization of a gown, change of gloves after every patient contact, and strict hand washing precautions. This level of precaution is utilized when multi-drug resistant organisms (e.g.
    [Show full text]
  • What Is Sepsis?
    What is sepsis? Sepsis is a serious medical condition resulting from an infection. As part of the body’s inflammatory response to fight infection, chemicals are released into the bloodstream. These chemicals can cause blood vessels to leak and clot, meaning organs like the kidneys, lung, and heart will not get enough oxygen. The blood clots can also decrease blood flow to the legs and arms leading to gangrene. There are three stages of sepsis: sepsis, severe sepsis, and ultimately septic shock. In the United States, there are more than one million cases with more than 258,000 deaths per year. More people die from sepsis each year than the combined deaths from prostate cancer, breast cancer, and HIV. More than 50 percent of people who develop the most severe form—septic shock—die. Septic shock is a life-threatening condition that happens when your blood pressure drops to a dangerously low level after an infection. Who is at risk? Anyone can get sepsis, but the elderly, infants, and people with weakened immune systems or chronic illnesses are most at risk. People in healthcare settings after surgery or with invasive central intravenous lines and urinary catheters are also at risk. Any type of infection can lead to sepsis, but sepsis is most often associated with pneumonia, abdominal infections, or kidney infections. What are signs and symptoms of sepsis? The initial symptoms of the first stage of sepsis are: A temperature greater than 101°F or less than 96.8°F A rapid heart rate faster than 90 beats per minute A rapid respiratory rate faster than 20 breaths per minute A change in mental status Additional symptoms may include: • Shivering, paleness, or shortness of breath • Confusion or difficulty waking up • Extreme pain (described as “worst pain ever”) Two or more of the symptoms suggest that someone is becoming septic and needs immediate medical attention.
    [Show full text]
  • Post-Typhoid Anhidrosis: a Clinical Curiosity
    Post-typhoid anhidrosis 435 Postgrad Med J: first published as 10.1136/pgmj.71.837.435 on 1 July 1995. Downloaded from Post-typhoid anhidrosis: a clinical curiosity V Raveenthiran Summary family physician. Shortly after convalescence A 19-year-old girl developed generalised she felt vague discomfort and later recognised anhidrosis following typhoid fever. Elab- that she was not sweating as before. In the past orate investigations disclosed nothing seven years she never noticed sweating in any abnormal. A skin biopsy revealed the part ofher body. During the summer and after presence of atrophic as well as normal physical exercise she was disabled by an eccrine glands. This appears to be the episodic rise of body temperature (41.4°C was third case of its kind in the English recorded once). Such episodes were associated literature. It is postulated that typhoid with general malaise, headache, palpitations, fever might have damaged the efferent dyspnoea, chest pain, sore throat, dry mouth, pathway of sweating. muscular cramps, dizziness, syncope, inability to concentrate, and leucorrhoea. She attained Keywords: anhidrosis, hypohidrosis, sweat gland, menarche at the age of 12 and her menstrual typhoid fever cycles were normal. Hypothalamic functions such as hunger, thirst, emotions, libido, and sleep were normal. Two years before admission Anhidrosis is defined as the inability of the she had been investigated at another centre. A body to produce and/or deliver sweat to the skin biopsy performed there reported normal skin surface in the presence of an appropriate eccrine sweat glands. stimulus and environment' and has many forms An elaborate physical examination ofgeneral (box 1).
    [Show full text]
  • Development of a Large Animal Model of Lethal Polytrauma and Intra
    Open access Original research Trauma Surg Acute Care Open: first published as 10.1136/tsaco-2020-000636 on 1 February 2021. Downloaded from Development of a large animal model of lethal polytrauma and intra- abdominal sepsis with bacteremia Rachel L O’Connell, Glenn K Wakam , Ali Siddiqui, Aaron M Williams, Nathan Graham, Michael T Kemp, Kiril Chtraklin, Umar F Bhatti, Alizeh Shamshad, Yongqing Li, Hasan B Alam, Ben E Biesterveld ► Additional material is ABSTRACT abdomen and pelvic contents. The same review published online only. To view, Background Trauma and sepsis are individually two of showed that of patients with whole body injuries, please visit the journal online 1 (http:// dx. doi. org/ 10. 1136/ the leading causes of death worldwide. When combined, 37.9% had penetrating injuries. The abdomen is tsaco- 2020- 000636). the mortality is greater than 50%. Thus, it is imperative one area of the body which is particularly suscep- to have a reproducible and reliable animal model to tible to penetrating injuries.2 In a review of patients Surgery, Michigan Medicine, study the effects of polytrauma and sepsis and test novel in Afghanistan with penetrating abdominal wounds, University of Michigan, Ann treatment options. Porcine models are more translatable the majority of injuries were to the gastrointes- Arbor, Michigan, USA to humans than rodent models due to the similarities tinal tract with the most common injury being to 3 Correspondence to in anatomy and physiological response. We embarked the small bowel. While this severe constellation Dr Glenn K Wakam; gw akam@ on a study to develop a reproducible model of lethal of injuries is uncommon in the civilian setting, med.
    [Show full text]
  • Essentials of Sepsis Management
    Essentials of Sepsis Management John M. Green, MD KEYWORDS Sepsis Sepsis syndrome Surgical infection Septic shock Goal-directed therapy KEY POINTS Successful treatment of perioperative sepsis relies on the early recognition, diagnosis, and aggressive treatment of the underlying infection; delay in resuscitation, source control, or antimicrobial therapy can lead to increased morbidity and mortality. When sepsis is suspected, appropriate cultures should be obtained immediately so that antimicrobial therapy is not delayed; initiation of diagnostic tests, resuscitative measures, and therapeutic interventions should otherwise occur concomitantly to ensure the best outcome. Early, aggressive, invasive monitoring is appropriate to ensure adequate resuscitation and to observe the response to therapy. Any patient suspected of having sepsis should be in a location where adequate resources can be provided. INTRODUCTION Sepsis is among the most common conditions encountered in critical care, and septic shock is one of the leading causes of morbidity and mortality in the intensive care unit (ICU). Indeed, sepsis is among the 10 most common causes of death in the United States.1 Martin and colleagues2 showed that surgical patients account for nearly one-third of sepsis cases in the United States. Despite advanced knowledge in the field, sepsis remains a common threat to life in the perioperative period. Survival relies on early recognition and timely targeted correction of the syndrome’s root cause as well as ongoing organ support. The objective of this article is to review strategies for detection and timely management of sepsis in the perioperative surgical patient. A comprehensive review of the molecular and cellular mechanisms of organ dysfunc- tion and sepsis management is beyond the scope of this article.
    [Show full text]